Discovery of thiohydantoin based antagonists of androgen receptor with efficient degradation for the treatment of prostate cancer.
Eur J Med Chem
; 257: 115490, 2023 Sep 05.
Article
in En
| MEDLINE
| ID: mdl-37209451
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Receptors, Androgen
Limits:
Humans
/
Male
Language:
En
Journal:
Eur J Med Chem
Year:
2023
Document type:
Article
Country of publication: